Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, Schwartz S, Steffen B, Spriewald B, Heinicke T, Jäkel N, Westermann J, Nachtkamp K, Viardot A, Topp MS, Neumann M, Baldus CD, Gökbuget N, Brüggemann M (2024)


Publication Language: English

Publication Type: Journal article, Letter

Publication year: 2024

Journal

DOI: 10.1038/s41375-024-02209-7

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Burmeister, T., Ströh, A.-S., Kehden, B., Trautmann, H., Meyer, C., Marschalek, R.,... Brüggemann, M. (2024). Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia. Leukemia. https://doi.org/10.1038/s41375-024-02209-7

MLA:

Burmeister, Thomas, et al. "Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia." Leukemia (2024).

BibTeX: Download